|
Laboratory Corporation of America Holdings (LH) Avaliação DCF |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
Laboratory Corporation of America Holdings (LH) Bundle
Descubra o verdadeiro potencial da Laboratory Corporation of America Holdings (LH) com nossa calculadora avançada de DCF! Ajuste as principais suposições, explore vários cenários e avalie como diferentes fatores influenciam a avaliação da Corporação de Laboratório da America Holdings (LH) - tudo dentro de um modelo abrangente do Excel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13,978.5 | 16,120.9 | 14,876.8 | 12,161.6 | 13,008.9 | 12,889.4 | 12,771.0 | 12,653.6 | 12,537.4 | 12,422.2 |
| Revenue Growth, % | 0 | 15.33 | -7.72 | -18.25 | 6.97 | -0.91879 | -0.91879 | -0.91879 | -0.91879 | -0.91879 |
| EBITDA | 3,251.5 | 4,278.7 | 1,954.4 | 1,349.4 | 1,811.3 | 2,267.5 | 2,246.6 | 2,226.0 | 2,205.5 | 2,185.3 |
| EBITDA, % | 23.26 | 26.54 | 13.14 | 11.1 | 13.92 | 17.59 | 17.59 | 17.59 | 17.59 | 17.59 |
| Depreciation | 825.0 | 940.0 | 537.2 | 577.3 | 899.9 | 696.2 | 689.8 | 683.5 | 677.2 | 671.0 |
| Depreciation, % | 5.9 | 5.83 | 3.61 | 4.75 | 6.92 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 |
| EBIT | 2,426.5 | 3,338.7 | 1,417.2 | 772.1 | 911.4 | 1,571.2 | 1,556.8 | 1,542.5 | 1,528.3 | 1,514.3 |
| EBIT, % | 17.36 | 20.71 | 9.53 | 6.35 | 7.01 | 12.19 | 12.19 | 12.19 | 12.19 | 12.19 |
| Total Cash | 1,320.8 | 1,472.7 | 430.0 | 536.8 | 1,518.7 | 968.3 | 959.4 | 950.6 | 941.9 | 933.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3,016.6 | 2,978.3 | 1,997.3 | 2,098.7 | 2,097.0 | 2,239.1 | 2,218.5 | 2,198.1 | 2,177.9 | 2,157.9 |
| Account Receivables, % | 21.58 | 18.47 | 13.43 | 17.26 | 16.12 | 17.37 | 17.37 | 17.37 | 17.37 | 17.37 |
| Inventories | 423.2 | 401.4 | 470.6 | 474.6 | 493.2 | 422.1 | 418.2 | 414.4 | 410.6 | 406.8 |
| Inventories, % | 3.03 | 2.49 | 3.16 | 3.9 | 3.79 | 3.27 | 3.27 | 3.27 | 3.27 | 3.27 |
| Accounts Payable | 638.9 | 621.3 | 852.2 | 827.5 | 875.8 | 713.8 | 707.2 | 700.7 | 694.3 | 687.9 |
| Accounts Payable, % | 4.57 | 3.85 | 5.73 | 6.8 | 6.73 | 5.54 | 5.54 | 5.54 | 5.54 | 5.54 |
| Capital Expenditure | -381.7 | -460.4 | -481.9 | -453.6 | -489.9 | -420.7 | -416.9 | -413.1 | -409.3 | -405.5 |
| Capital Expenditure, % | -2.73 | -2.86 | -3.24 | -3.73 | -3.77 | -3.26 | -3.26 | -3.26 | -3.26 | -3.26 |
| Tax Rate, % | 22.25 | 22.25 | 22.25 | 22.25 | 22.25 | 22.25 | 22.25 | 22.25 | 22.25 | 22.25 |
| EBITAT | 1,701.5 | 2,538.6 | 1,145.4 | 567.3 | 708.6 | 1,188.5 | 1,177.6 | 1,166.7 | 1,156.0 | 1,145.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -656.1 | 3,060.7 | 2,343.4 | 560.9 | 1,150.0 | 1,231.0 | 1,468.4 | 1,454.9 | 1,441.6 | 1,428.3 |
| WACC, % | 6.48 | 6.54 | 6.59 | 6.51 | 6.56 | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,812.5 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 1,478 | |||||||||
| Terminal Value | 48,714 | |||||||||
| Present Terminal Value | 35,498 | |||||||||
| Enterprise Value | 41,310 | |||||||||
| Net Debt | 5,754 | |||||||||
| Equity Value | 35,556 | |||||||||
| Diluted Shares Outstanding, MM | 84 | |||||||||
| Equity Value Per Share | 421.28 |
What You Will Receive
- Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-filled financials for Laboratory Corporation of America Holdings (LH).
- Accurate Data: Historical data along with forward-looking estimates (highlighted in the yellow cells).
- Flexible Forecasting: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect the valuation of Laboratory Corporation of America Holdings (LH).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for clarity and user-friendliness, complete with step-by-step guidance.
Key Features
- 🔍 Real-Life LH Financials: Pre-filled historical and projected data for Laboratory Corporation of America Holdings (LH).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Laboratory Corporation of America’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Laboratory Corporation of America’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Template: Download and open the Excel file containing Laboratory Corporation of America Holdings (LH) preloaded data.
- 2. Adjust Assumptions: Modify key inputs such as growth rates, WACC, and capital expenditures to fit your analysis.
- 3. View Results Instantly: The DCF model will automatically calculate intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
- 5. Present with Confidence: Deliver professional valuation insights to back your strategic decisions.
Why Choose This Calculator for Laboratory Corporation of America Holdings (LH)?
- Designed for Experts: A sophisticated tool tailored for analysts, CFOs, and healthcare consultants.
- Accurate Financial Data: Historical and projected financials for Laboratory Corporation of America preloaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Clear, step-by-step guidance to facilitate your calculations.
Who Should Use This Product?
- Investors: Evaluate Laboratory Corporation of America Holdings’ (LH) valuation before making investment decisions.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Understand the valuation strategies of established companies like Laboratory Corporation of America Holdings (LH).
- Consultants: Provide comprehensive valuation analyses and reports for clients.
- Students and Educators: Utilize real-time data to learn and teach valuation practices.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations for Laboratory Corporation of America Holdings (LH).
- Real-World Data: Laboratory Corporation of America Holdings (LH)’s historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.